Patient Square Capital LP
29 holdingsFiling period: 2026-03-31Current AUM: $569.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | ROIVANT SCIENCES LTD | 8.17M | $226.2M | $226.2M | 39.73% | -- | 2026-03-31 |
| 2 | ARGX | ARGENX SE | 36.7K | $26.8M | $31.4M | 5.51% | +10.7K | 2026-03-31 |
| 3 | INSM | INSMED INC | 157.5K | $25.8M | $15.5M | 2.73% | -109,500 | 2026-03-31 |
| 4 | ONC | BEONE MEDICINES LTD | 80.5K | $23.9M | $25.5M | 4.47% | +11.2K | 2026-03-31 |
| 5 | COGT | COGENT BIOSCIENCES INC | 596.0K | $22.9M | $23.2M | 4.08% | +278.6K | 2026-03-31 |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | 230.0K | $21.2M | $24.4M | 4.28% | -68,682 | 2026-03-31 |
| 7 | BLTE | BELITE BIO INC | 116.7K | $18.6M | $18.5M | 3.25% | -- | 2026-03-31 |
| 8 | LEGN | LEGEND BIOTECH CORP | 990.0K | $17.9M | $18.4M | 3.23% | -- | 2026-03-31 |
| 9 | NKTR | NEKTAR THERAPEUTICS | 210.0K | $15.1M | $14.8M | 2.61% | -- | 2026-03-31 |
| 10 | DBVT | DBV TECHNOLOGIES S A | 693.5K | $14.5M | $9.4M | 1.64% | +334.5K | 2026-03-31 |
| 11 | — | PHARVARIS N V | 493.0K | $13.9M | $13.9M | 2.45% | -49,696 | 2026-03-31 |
| 12 | ABVX | ABIVAX SA | 121.2K | $13.5M | $15.1M | 2.66% | -8,755 | 2026-03-31 |
| 13 | XENE | XENON PHARMACEUTICALS INC | 227.0K | $13.2M | $14.2M | 2.50% | +90.5K | 2026-03-31 |
| 14 | CELC | CELCUITY INC | 95.0K | $10.8M | $8.2M | 1.44% | -25,000 | 2026-03-31 |
| 15 | EYPT | EYEPOINT INC | 795.0K | $10.2M | $9.7M | 1.71% | +15.0K | 2026-03-31 |
| 16 | MRK | MERCK & CO INC | 80.0K | $9.6M | $10.4M | 1.83% | -- | 2026-03-31 |
| 17 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 400.6K | $9.4M | $10.8M | 1.89% | +190.6K | 2026-03-31 |
| 18 | ALLO | ALLOGENE THERAPEUTICS INC | 3.45M | $8.4M | $6.5M | 1.14% | -1,513,756 | 2026-03-31 |
| 19 | KYMR | KYMERA THERAPEUTICS INC | 100.0K | $8.3M | $10.3M | 1.82% | -39,000 | 2026-03-31 |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | 93.9K | $7.9M | $10.0M | 1.76% | -56,118 | 2026-03-31 |
| 21 | ELVN | ENLIVEN THERAPEUTICS INC | 200.0K | $7.8M | $11.0M | 1.93% | -108,141 | 2026-03-31 |
| 22 | CATX | PERSPECTIVE THERAPEUTICS INC | 1.63M | $6.8M | $4.7M | 0.83% | +492.2K | 2026-03-31 |
| 23 | DFTX | DEFINIUM THERAPEUTICS INC | 331.0K | $6.3M | $14.4M | 2.53% | -- | 2026-03-31 |
| 24 | HROW | HARROW INC | 165.2K | $5.8M | $6.4M | 1.12% | +158.2K | 2026-03-31 |
| 25 | TARA | PROTARA THERAPEUTICS INC | 1.03M | $5.4M | $4.0M | 0.71% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2